UroGen Pharma Ltd.
URGN
$9.87
-$0.24-2.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 72.80% | 69.30% | 409.67% | 152.17% | 37.02% |
| Total Receivables | 31.46% | 77.49% | 12.32% | 13.33% | 21.56% |
| Inventory | 62.65% | 51.82% | 49.20% | 32.51% | 31.17% |
| Prepaid Expenses | -13.97% | -12.38% | -4.05% | -13.63% | -7.39% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 31.06% | 31.33% | 1.10% | 1.11% | 0.98% |
| Total Current Assets | 63.21% | 62.03% | 242.99% | 105.02% | 31.25% |
|
|
|||||
| Total Current Assets | 63.21% | 62.03% | 242.99% | 105.02% | 31.25% |
| Net Property, Plant & Equipment | 60.55% | -39.15% | -39.34% | -41.46% | -37.05% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -66.20% | -76.04% | -72.11% | -60.87% | -23.62% |
| Total Assets | 60.23% | 55.94% | 195.56% | 77.57% | 31.48% |
|
|
|||||
| Total Accounts Payable | 67.81% | 37.49% | 78.51% | -10.18% | 17.86% |
| Total Accrued Expenses | 29.91% | 27.28% | 20.69% | 11.96% | 37.88% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 86.81% | -3.85% | -12.53% | -19.52% | -12.96% |
| Total Finance Division Other Current Liabilities | 111.05% | 20.52% | 3.41% | 9.07% | 30.24% |
| Total Other Current Liabilities | 111.05% | 20.52% | 3.41% | 9.07% | 30.24% |
| Total Current Liabilities | 47.22% | 27.14% | 27.86% | 4.38% | 30.51% |
|
|
|||||
| Total Current Liabilities | 47.22% | 27.14% | 27.86% | 4.38% | 30.51% |
| Long-Term Debt | 23.52% | 23.54% | -0.49% | -0.36% | 1.04% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 95.85% | -79.34% | -64.85% | -54.60% | -46.78% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.86% | 10.36% | 10.74% | 10.68% | 10.77% |
| Total Liabilities | 20.94% | 17.32% | 7.59% | 4.88% | 8.24% |
|
|
|||||
| Common Stock & APIC | 29.84% | 29.85% | 57.22% | 36.82% | 25.88% |
| Retained Earnings | -18.68% | -17.66% | -17.99% | -17.18% | -17.72% |
| Treasury Stock & Other | 366.67% | 276.12% | 79.87% | 17.78% | 111.21% |
| Total Common Equity | 86.50% | 160.76% | 121.90% | 65.57% | 27.02% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 86.50% | 160.76% | 121.90% | 65.57% | 27.02% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 86.50% | 160.76% | 121.90% | 65.57% | 27.02% |
|
|
|||||